SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000912282-16-000695
Filing Date
2016-04-25
Accepted
2016-04-25 14:20:19
Documents
2
Period of Report
2016-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 arbutus8k_04212016.htm 8-K 27657
2 PRESS RELEASE DATED APRIL 21, 2016 ex99_1.htm EX-99.1 15155
  Complete submission text file 0000912282-16-000695.txt   44287
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 161588640
SIC: 2834 Pharmaceutical Preparations